These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 1899470
1. Recognition of gonadotroph adenomas in women. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ. N Engl J Med; 1991 Feb 28; 324(9):589-94. PubMed ID: 1899470 [Abstract] [Full Text] [Related]
2. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ. J Clin Endocrinol Metab; 1993 Nov 28; 77(5):1352-5. PubMed ID: 8077332 [Abstract] [Full Text] [Related]
3. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR, Kwekkeboom DJ, Coopmans W, Hoekstra R, De Herder WW, Bouillon R, Lamberts SW. J Clin Endocrinol Metab; 1993 Sep 28; 77(3):784-9. PubMed ID: 7690365 [Abstract] [Full Text] [Related]
7. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture. Snyder PJ, Bashey HM, Phillips JL, Gennarelli TA. J Clin Endocrinol Metab; 1985 Dec 28; 61(6):1061-5. PubMed ID: 2414310 [Abstract] [Full Text] [Related]
8. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ, de Jong FH, Lamberts SW. J Clin Endocrinol Metab; 1989 Jun 28; 68(6):1128-35. PubMed ID: 2542356 [Abstract] [Full Text] [Related]
9. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H. J Clin Endocrinol Metab; 1989 Jan 28; 68(1):81-6. PubMed ID: 2535852 [Abstract] [Full Text] [Related]
10. The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors. Popovic V, Damjanovic S. Thyroid; 1998 Oct 28; 8(10):935-9. PubMed ID: 9827662 [Abstract] [Full Text] [Related]
11. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Gil-del-Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck-Peccoz P. Clin Endocrinol (Oxf); 1994 Nov 28; 41(5):661-6. PubMed ID: 7828356 [Abstract] [Full Text] [Related]
12. Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. Snyder PJ, Muzyka R, Johnson J, Utiger RD. J Clin Endocrinol Metab; 1980 Oct 28; 51(4):744-8. PubMed ID: 6774992 [Abstract] [Full Text] [Related]
13. Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas. Blanco C, Lucas T, Alcañiz J, Davila N, Serrano P, Barcelò B, Estrada J. J Endocrinol Invest; 1994 Feb 28; 17(2):99-104. PubMed ID: 8006339 [Abstract] [Full Text] [Related]
14. LH- and FSH-secreting pituitary adenoma in a postmenopausal woman. Hattori N, Ishihara T, Moridera K, Ikekubo K, Hino M, Saiki Y, Kurahachi H. Endocrinol Jpn; 1991 Aug 28; 38(4):393-6. PubMed ID: 1802680 [Abstract] [Full Text] [Related]
15. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. Snyder PJ, Bashey HM, Kim SU, Chappel SC. J Clin Endocrinol Metab; 1984 Dec 28; 59(6):1169-75. PubMed ID: 6436288 [Abstract] [Full Text] [Related]
16. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas]. Sanno N, Teramoto A, Inada K, Osamura Y. No To Shinkei; 1992 Aug 28; 44(8):745-53. PubMed ID: 1419353 [Abstract] [Full Text] [Related]
17. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. Daneshdoost L, Pavlou SN, Molitch ME, Gennarelli TA, Savino PJ, Sergott RC, Bosley TM, River JE, Vale WW, Snyder PJ. J Clin Endocrinol Metab; 1990 Jul 28; 71(1):92-7. PubMed ID: 2115048 [Abstract] [Full Text] [Related]
19. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women. Aparicio NJ, Casas PR, Galimberti DM, de Laborde NP, Badano A, García EP, Meichi HR, Mirkin A, Szejner M, Jaitt A, Margulies M, Rosner JM. Int J Fertil; 1977 Sep 28; 22(1):6-15. PubMed ID: 18416 [Abstract] [Full Text] [Related]
20. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology. Asa SL, Cheng Z, Ramyar L, Singer W, Kovacs K, Smyth HS, Muller P. J Clin Endocrinol Metab; 1992 May 28; 74(5):1128-34. PubMed ID: 1569159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]